Save information for later
Sign Up

Learn About Neonatal Herpes

Who are the top Neonatal Herpes Local Doctors?
2650 Ridge Ave, Evanston Hospital, 
Evanston, IL 
 (3.7 mi)
Languages Spoken:
English

Joseph Hageman is a Pediatrics provider in Evanston, Illinois. Dr. Hageman and is rated as an Experienced provider by MediFind in the treatment of Neonatal Herpes. His top areas of expertise are Sudden Infant Death Syndrome (SIDS), Genetic Epilepsy with Febrile Seizures Plus (GEFS+), High Blood Pressure in Infants, and Neonatal Herpes.

Pediatric Infectious Disease | Infectious Disease | Pediatrics
Pediatric Infectious Disease | Infectious Disease | Pediatrics
225 E Chicago Ave, 
Chicago, IL 
 (11.2 mi)
Languages Spoken:
English

Lisa Akhtar is a Pediatric Infectious Disease specialist and an Infectious Disease provider in Chicago, Illinois. Dr. Akhtar and is rated as a Distinguished provider by MediFind in the treatment of Neonatal Herpes. Her top areas of expertise are Neonatal Herpes, Herpes Simplex Encephalitis, Oral Herpes, and Meningitis.

 
 
 
 
Learn about our expert tiers
Learn More
Pediatric Infectious Disease | Infectious Disease
Pediatric Infectious Disease | Infectious Disease

Pediatric Faculty Foundation Inc

225 E Chicago Ave, 
Chicago, IL 
 (11.2 mi)
Languages Spoken:
English

William Muller is a Pediatric Infectious Disease specialist and an Infectious Disease provider in Chicago, Illinois. Dr. Muller and is rated as a Distinguished provider by MediFind in the treatment of Neonatal Herpes. His top areas of expertise are Neonatal Herpes, Severe Acute Respiratory Syndrome (SARS), Herpes Simplex Encephalitis, and COVID-19.

What are the latest Neonatal Herpes Clinical Trials?
A Phase I Adaptive, Multiple Dose Pharmacokinetic and Safety Assessment of Valacyclovir in Infants at Risk of Acquiring Neonatal Herpes Simplex Virus Disease

Summary: A Phase 1 study that will determine the valacyclovir dose that results in a systemic acyclovir exposure comparable to 10 mg/kg of parenterally administered acyclovir, which is an AUC0-12 of 24,000 ngxhr/mL to 48,000 ngxhr/mL. Neonates at risk of acquiring neonatal HSV will be enrolled in one of 2 cohorts. Cohort 1 will be comprised of eight subjects who will receive an initial dose of 10ml/kg of o...

Match to trials
Find the right clinical trials for you in under a minute
Get started
Who are the sources who wrote this article ?

Published Date: May 10, 2022
Published By: Genetic and Rare Diseases Informnation Center